DR. RALPH F. HEAVEN M.D. NPI 1023056280

NPI Information

  • NPI: 1023056280
  • Provider Name: DR. RALPH F. HEAVEN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1100 N 19TH ST
    SUITE 1A
    ABILENE, TX
    ZIP 79601
  • Phone: (325) 672-4368

Map and Directions

Get Directions

NPI Details

DR. Ralph F. Heaven, M.D. is a hematology and oncology internal medicine in Abilene, TX with 42 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Ralph F. Heaven, M.D. NPI is 1023056280. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1100 N 19TH ST
SUITE 1A
ABILENE, TX
ZIP 79601-344
Phone: (325) 672-4368
Fax: (325) 672-3108

The NPI 1023056280 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Blood creatinine level (HCPCS:82565)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Blood potassium level (HCPCS:84132)
  • Blood chloride level (HCPCS:82435)
  • Phosphatase (enzyme) level, alkaline (HCPCS:84075)
  • Total protein level, blood (HCPCS:84155)
  • Liver enzyme (sgot), level (HCPCS:84450)
  • Liver enzyme (sgpt), level (HCPCS:84460)
  • Albumin (protein) level (HCPCS:82040)
  • Bilirubin level, total (HCPCS:82247)
  • Calcium level, total (HCPCS:82310)
  • Carbon dioxide (bicarbonate) level (HCPCS:82374)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Magnesium level (HCPCS:83735)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Ct scan of chest without contrast (HCPCS:71250)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes (HCPCS:99421)
  • Hospital discharge day management, 30 minutes or less (HCPCS:99238)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Ct scan of abdomen with contrast (HCPCS:74160)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes (HCPCS:99422)

The enumeration date for this NPI number is 6/2/2006 and was last updated on 2/18/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyK0817TEXASNo
2207RH0003XInternal MedicineHematology & OncologyK0817TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1045771501MEDICAIDTEXAS
2G27268MEDICARE UPINTEXAS
387791KMEDICARE PINTEXAS
4104037002MEDICAIDTEXAS
58R1457OTHERTEXASBLUE CROSS OF TEXAS
6104037001MEDICAIDTEXAS
7900001035MEDICARE PINTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.